Atorvastatin Oxirane Impurity is a chemical compound identified as a process-related byproduct in the synthesis of atorvastatin, a statin medication. It is defined by an oxirane ring structure containing a fluorobenzoyl and diphenylcarboxamide group, and is primarily used as a reference standard in pharmaceutical quality control and research.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1246818-88-1
2-((5-Bromopyrimidin-2-yl)oxy)ethan-1-ol
n.a
5,6-Dihydroxy-2,3-dihydro-1H-inden-1-one
n.a
N-[(E)-1-cyclohexa-2,4-dien-1-yl-3-phenylprop-2-enylidene]-4-[2,5-di(carbazol-9-yl)carbazol-9-yl]-3,5-diphenylbenzenecarboximidamide
n.a
2-Ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine
n.a
3-((4-Fluorophenyl)carbonyl)-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide
atorvastatin impurity reference standard
3-(4-fluorobenzoyl)-2-(2-methylpropyl)-N,3-diphenyloxirane-2-carboxamide
WTTRRISNQAPVTN-UHFFFAOYSA-N
CC(C)CC1(C(O1)(C2=CC=CC=C2)C(=O)C3=CC=C(C=C3)F)C(=O)NC4=CC=CC=C4